ted company mbining the va s entered int rcent. Accord ited (“the ary shares nsurance, e detail of ix from s which -up enhance by using diligence with those with the alue of the to by the dingly, the
sold increased 24.47 percent from the same period of last year, which accord with higher sales volume. Selling expenses on year 2017 and 4th quarter increased 29.14 and 67.67 percent accordingly from the
B.E. 2539 to 30th September B.E. 2540, the procedure of which shall accord with criteria and procedure specified in Clause 3. [Added by the Ministerial Regulation No. 7 (B.E. 2539) promulgated under the
Ticker ARKF CUSIP 00214Q708 @&& @/7(Benchmark) - S&P 500 Index - MSCI World Index 6ก7 USD MN@ก!ก (Manager) ARK Investment Management LLC 12 3JR"5 (website) www.ark-funds.com !!*$&N"y Management Fee ก3N!7
-term loan bentures es bilities ilities quity ng 30 June qual to 114 t receivable lder Equity ding 30 Jun 6 at 161.7 m cial institutio on baht from t Bearing D to consiste Moreover, th 7 as accord 017 1
,*$, ก 7ก!Y, Fund Ticker ARKQ CUSIP 00214Q203 K&& K/8(Benchmark) - S&P 500 Index - MSCI World Index 6ก8 USD TUKก!ก (Manager) ARK Investment Management LLC 3QY"5 (website) www.ark-funds.com !!*$&U"w
changing the Company’s seal, and still using the ticker of “EASON” 6.2 The change of Company’s Memorandum of association 1) Amend clause 1 (Company’s name) to be consistent with the change of the Company’s
*( & '%*-#H $ TCR /* /%$$$ * %B`+'* && #% A(* * ". * VEMEX Description Ticker Market ISIN CODE CUSIP CODE Ishares MSCI Pacific ex Japan Index Fund EPP AMEX US4642866655 464286665 Telefonaktiebolaget
Clause 4 to ing No. 6/201 ers No. 2/20 Newly Issued d (the “Comp ectors’ Meetin of Shareholde the existing r ary shares of t ht 1.00 per s o be in accord ector and/or a d to have th Business Deve der in
Ticker ARKG CUSIP 00214Q 302 ISIN US00214Q3020 ดชันีชีว้ดั/อ้างอิง(Benchmark) - NASDAQ Biotech. Index - S&P 500 Index - MSCI World Index Index ticker - XNBI Index - SPX Index - M1WO Index สกลุเงิน USD ผู้